ESSEX CORPORATION
10QSB, 1998-10-21
ENGINEERING SERVICES
Previous: KUALA HEALTHCARE INC, 10-K, 1998-10-21
Next: TRUSTCO BANK CORP N Y, 8-K, 1998-10-21




                                   FORM 10-QSB
                     U.S. SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549


[X]   QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE
      SECURITIES AND EXCHANGE ACT OF 1934

               For the quarterly period ended September 27, 1998.


                         Commission File Number 0-10772


                                ESSEX CORPORATION
        (Exact name of small business issuer as specified in its charter)

         Virginia                                                   54-0846569
(State or other jurisdiction of                               (I.R.S. Employer
incorporation or organization)                             Identification No.)

9150 Guilford Road, Columbia, Maryland                              21046-1891
(Address of principal executive offices)                            (Zip Code)

Issuer's telephone number, including area code: (301) 939-7000


Check  whether  the issuer  (1) has filed all  reports  required  to be filed by
Section 13 or 15(d) of the  Securities  Exchange  Act of 1934 during the past 12
months (or for such shorter period that the registrant was required to file such
reports),  and (2) has been subject to such filing  requirements for the past 90
days.

YES       X       NO

State the number of shares  outstanding  of each of the issuer's class of Common
Stock as of the latest practicable date.

                                                               OUTSTANDING
                CLASS                                    AT SEPTEMBER 27, 1998
                -----                                    ---------------------
Common Stock, par value $0.10 per share                          4,397,861

Transitional Small Business Disclosure Format (Check One);

YES       X       NO



<PAGE>


                                ESSEX CORPORATION

                         PART I - FINANCIAL INFORMATION


ITEM 1.         FINANCIAL STATEMENTS

The  interim  financial   statements  are  unaudited  but,  in  the  opinion  of
management,  reflect all adjustments for a fair presentation of results for such
period.  The results of operations  for any interim  period are not  necessarily
indicative of results for the full year.  These financial  statements  should be
read in conjunction with the financial statements and notes thereto contained in
the  Company's  Annual  Report on Form  10-KSB/A No. 1 for the fiscal year ended
December 28, 1997.



                                        2

<PAGE>


                                ESSEX CORPORATION
<TABLE>

                                 BALANCE SHEETS
<CAPTION>


                                                              September 27,       December 28,
                                                                  1998                1997
                                                               (unaudited)          (audited)
     ASSETS


CURRENT ASSETS
<S>                                                       <C>                 <C>           
  Cash                                                    $      231,542      $      367,136
  Accounts receivable, net                                       933,725             469,427
  Inventory                                                      401,394             399,488
  Prepayments and other                                           44,286              65,483
  Note receivable and other                                           --             411,742
  Net current assets of discontinued operations                       --              31,098
                                                          --------------      --------------
                                                               1,610,947           1,744,374
                                                          --------------      --------------


PROPERTY AND EQUIPMENT
  Production and special equipment                               909,137             875,983
  Furniture, equipment and other                                 510,116             592,428
                                                          --------------      --------------
                                                               1,419,253           1,468,411
  Accumulated depreciation and amortization                   (1,317,405)         (1,227,806)
                                                          --------------      --------------
                                                                 101,848             240,605
                                                          --------------      --------------

OTHER ASSETS
  Patents, net                                                   157,872             175,374
  Deferred debenture financing                                     9,992              20,928
  Other                                                           29,426              32,445
  Net noncurrent assets of discontinued operations                    --             977,256
                                                          --------------      --------------
                                                                 197,290           1,206,003
                                                          --------------      --------------

TOTAL ASSETS                                              $    1,910,085      $    3,190,982
- ------------                                              ==============      ==============



<FN>

The accompanying notes are an integral part of these statements.
</FN>
</TABLE>


                                        3

<PAGE>


                                ESSEX CORPORATION
<TABLE>

                                 BALANCE SHEETS
<CAPTION>


                                                                September 27,        December 28,
                                                                    1998                 1997
                                                                 (unaudited)           (audited)
     LIABILITIES AND STOCKHOLDERS' EQUITY


CURRENT LIABILITIES
<S>                                                            <C>                  <C>            
  Current portion of capital leases                            $       21,853       $        51,835
  Advance from accounts receivable financing                          198,940                    --
  Bank line of credit                                                      --               163,874
  Accounts payable                                                    231,133               301,195
  Accrued wages and vacation                                          206,352               151,887
  Accrued lease settlement                                            249,020               281,531
  Other accrued expenses                                              212,554               328,442
                                                               --------------       ---------------
                                                                    1,119,852             1,278,764

LONG-TERM DEBT
  10% Convertible Collateralized Debentures                           375,714             1,233,100
  Capital leases, net of current portion                                   --                13,140
                                                               --------------       ---------------

  Total Liabilities                                                 1,495,566             2,525,004
                                                               --------------       ---------------

COMMITMENTS AND CONTINGENCIES (NOTE 4)

STOCKHOLDERS' EQUITY
  Common stock, $0.10 par value; 25 million shares
    authorized; 4,397,861 and 4,134,065 shares issued
    and outstanding for 1998 and 1997, respectively                   439,786               413,406
  Redeemable preferred stock, $0.01 par value; 1 million 
    total shares authorized; 2,500 shares of Series A
    authorized; -0- and 1,200 shares issued and
    outstanding for 1998 and 1997, respectively                            --               120,000
  Contributions in excess of par value                              5,634,234             5,519,496
  Retained deficit                                                 (5,659,501)           (5,386,924)
                                                               --------------       ---------------
                                                                      414,519               665,978
                                                               --------------       ---------------

TOTAL LIABILITIES AND
  STOCKHOLDERS' EQUITY                                         $    1,910,085       $     3,190,982
  --------------------                                         ==============       ===============
<FN>

The accompanying notes are an integral part of these statements.
</FN>
</TABLE>

                                        4

<PAGE>


                                ESSEX CORPORATION
<TABLE>

                            STATEMENTS OF OPERATIONS
                        FOR THE THIRTY-NINE WEEK PERIODS
                 ENDED SEPTEMBER 27, 1998 AND SEPTEMBER 28, 1997
<CAPTION>


                                                                    1998                1997
                                                                 (unaudited)         (unaudited)

<S>                                                             <C>                 <C>         
Revenues                                                        $  3,312,855        $  2,998,648
Cost of goods sold and services provided                          (1,770,145)         (1,474,583)
Engineering and product development expenses                        (344,889)           (471,990)
Selling, general and administrative expenses                      (1,370,957)         (1,940,258)
                                                                ------------        ------------

    Operating Loss                                                  (173,136)           (888,183)

Interest expense, net and debenture financing amortization           (99,441)           (192,462)
                                                                ------------        ------------

Loss from Continuing Operations
  Before Income Taxes                                               (272,577)         (1,080,645)

Benefit from income taxes                                                 --                  --
                                                                ------------        ------------

Loss from Continuing Operations                                     (272,577)         (1,080,645)
                                                                ------------        ------------

Discontinued Operations (Note 8):

    Loss from operations                                                  --            (100,973)

    Gain on disposal                                                      --             266,698
                                                                ------------        ------------

Income from Discontinued Operations                                       --             165,725
                                                                ------------        ------------

Net Loss                                                        $   (272,577)       $   (914,920)
                                                                ============        ============
Weighted Average Number of Shares
  Outstanding                                                      4,250,519           3,626,036
                                                                ============        ============

Basic Earnings (Loss) Per Share:
  Continuing Operations                                         $      (0.06)       $      (0.30)
  Discontinued Operations                                                 --                0.05
                                                                ------------        ------------
                                                                $      (0.06)       $      (0.25)
                                                                ============        ============

<FN>

The accompanying notes are an integral part of these statements.
</FN>
</TABLE>

                                        5

<PAGE>


                                ESSEX CORPORATION
<TABLE>

                            STATEMENTS OF OPERATIONS
                          FOR THE THIRTEEN WEEK PERIODS
                 ENDED SEPTEMBER 27, 1998 AND SEPTEMBER 28, 1997
<CAPTION>


                                                                      1998                  1997
                                                                   (unaudited)          (unaudited)

<S>                                                              <C>                  <C>          
Revenues                                                         $   1,269,691        $     934,172
Cost of goods sold and services provided                              (663,814)            (471,535)
Engineering and product development expenses                           (73,379)             (82,934)
Selling, general and administrative expenses                          (447,000)            (499,841)
                                                                 -------------        -------------

    Operating Income (Loss)                                             85,498             (120,138)

Interest expense, net and debenture financing amortization             (18,963)             (75,912)
                                                                 -------------        -------------

Income (Loss) from Continuing Operations
  Before Income Taxes                                                   66,535             (196,050)

Benefit from income taxes                                                   --                   --
                                                                 -------------        -------------

Income (Loss) from Continuing Operations                                66,535             (196,050)

Discontinued Operations (Note 8):  Gain on disposal                         --              266,698
                                                                 -------------        -------------

Net Income                                                       $      66,535        $      70,648
                                                                 =============        =============

Weighted Average Number of Shares
  Outstanding                                                        4,397,861            3,626,098
                                                                 =============        =============

Basic Earnings (Loss) Per Share:
  Continuing Operations                                          $        0.02        $       (0.05)
  Discontinued Operations                                                   --                 0.07
                                                                 -------------        -------------
                                                                 $        0.02        $        0.02
                                                                 =============        =============

<FN>

The accompanying notes are an integral part of these statements.
</FN>
</TABLE>

                                        6

<PAGE>


                                ESSEX CORPORATION
<TABLE>

                            STATEMENTS OF CASH FLOWS
                        FOR THE THIRTY-NINE WEEK PERIODS
                 ENDED SEPTEMBER 27, 1998 AND SEPTEMBER 28, 1997
<CAPTION>


                                                                         1998             1997
                                                                      (unaudited)      (unaudited)
CASH FLOWS FROM OPERATING ACTIVITIES:
<S>                                                                 <C>               <C>         
  Net Loss                                                          $   (272,577)     $  (914,920)
  Adjustments to reconcile Net Loss to Net Cash
  Used In Operating Activities:

      Depreciation and amortization                                      157,667          305,951
      Inventory valuation reserve                                         15,000               --
      Gain on sale of discontinued operations                                 --         (239,345)
      Other                                                               17,414           (2,331)

  Change in Assets and Liabilities:
      Accounts receivable                                               (464,298)         (49,122)
      Inventory                                                          (16,906)        (341,496)
      Prepayments and other assets                                        30,387           94,670
      Accounts payable                                                   (70,062)          20,828
      Accrued lease settlement                                           (32,511)          (8,686)
      Other liabilities                                                  (56,423)        (172,906)
      Non-cash charges and working capital
        changes of discontinued operations                               129,579         (272,182)
                                                                    ------------      -----------

  Net Cash Used In Operating Activities                                 (562,730)      (1,579,539)
                                                                    ------------      -----------


CASH FLOWS FROM INVESTING ACTIVITIES:
  Purchases of property and equipment                                       (734)          (7,437)
  Proceeds from sale of fixed assets                                       2,795            2,594
  Proceeds from sale of fixed assets of discontinued operations          878,775               --
  Proceeds from sale of discontinued operations                          411,742          425,000
                                                                    ------------      -----------

  Net Cash Provided By Investing Activities                            1,292,578          420,157
                                                                    ------------      -----------


CASH FLOWS FROM FINANCING ACTIVITIES:
  Short-term borrowings (repayments) on line of
   credit or receivables financing, net                                   35,066         (150,000)
  Issuance of convertible notes payable                                       --          245,000
  Issuance of preferred stock                                                 --          120,000
  Proceeds from exercises of stock options                                    --            2,520
  Repayment of convertible debentures                                   (857,386)              --
  Payment of capital lease obligations                                   (43,122)         (70,013)
                                                                    ------------      -----------


  Net Cash (Used In) Provided By Financing Activities                   (865,442)         147,507
                                                                    ------------      -----------


CASH AND CASH EQUIVALENTS
   Net decrease                                                         (135,594)      (1,011,875)
   Balance - beginning of period                                         367,136        1,507,603
                                                                    ------------      -----------
   Balance - end of period                                          $    231,542      $   495,728
                                                                    ============      ===========

<FN>

The accompanying notes are an integral part of these statements.
</FN>
</TABLE>

                                        7

<PAGE>


                                ESSEX CORPORATION

                     NOTES TO INTERIM FINANCIAL INFORMATION

NOTE 1:       General

FISCAL YEAR AND PRESENTATION

Essex  Corporation  (the  "Company") is on a 52-week fiscal year ending the last
Sunday in December.  Certain amounts for 1997 have been  reclassified to conform
to the 1998 presentation.

USE OF ESTIMATES

The preparation of financial  statements in conformity  with generally  accepted
accounting principles requires management to make estimates and assumptions that
affect  the  reported  amounts  of assets  and  liabilities  and  disclosure  of
contingent  assets and  liabilities at the date of the financial  statements and
the  reported  amounts of revenues  and expenses  during the  reporting  period.
Actual results could differ from those estimates.

IMPORTANT BUSINESS RISK FACTORS

The Company has historically  been principally a supplier of technical  services
under  contracts  or  subcontracts  with  departments  or  agencies  of the U.S.
Government,  primarily the military  services and other departments and agencies
of the Department of Defense.

Beginning in 1989, the Company has expended significant funds to transition into
the commercial  marketplace,  particularly the productization of its proprietary
technologies in optoelectronic  processors,  testing and evaluation. The success
of the Company in this area is dependent on its ability to successfully  develop
and market products  related to its  optoelectronic  processors.  The success of
these efforts is subject to changing  technologies,  availability  of financing,
competition, and ultimately market acceptance.

The Company has incurred losses since 1989, primarily due to the development and
marketing  of its  optoelectronics  products  and  services.  The  Company  also
experienced  difficulty in sustaining  and expanding  revenue  volume in certain
areas  of  the  Technical  Services  and  Products  business  segment  which  it
discontinued in 1997. The Optoelectronics Products and Services business segment
is  experiencing  net  cash  expenditures   (including  respective  general  and
administrative   expenses)   over   receipts  in  the  range  of   approximately
$25,000-$50,000 per month.

The Company is seeking  additional  funds to finance  operations  and to achieve
desired product inventory levels and initial market penetration.  The Company is
also seeking to establish  joint ventures or strategic  partnerships  with major
industrial  concerns to  facilitate  these goals.  Failure to  commercialize  or
significant   further   delays  in  the   commercialization   of  the  Company's
optoelectronic  products  would have a material  adverse effect on the Company's
future operating  results and future financial  position;  however,  the Company
believes  that in such  event it  could  successfully  manage  and  reduce  cash
requirements  for  operations  by  curtailing  expenditures  in  optoelectronics
operations (including general and administrative  expenses),  although there can
be no  assurances in this regard.  The Company  believes that it will be able to
meet its 1998

                                        8

<PAGE>


                                                ESSEX CORPORATION

funding  requirements  from  current  operations  and  from  the  aforementioned
sources, although there can be no assurances in this regard.

NOTE 2:       Basic Earnings (Loss) Per Share

Basic  earnings  (loss) per share has been  calculated  by dividing the earnings
(loss) by the weighted average number of common shares  outstanding  during each
of the periods presented.
Common stock equivalents were anti-dilutive.

NOTE 3:       Accounts Receivable Financing

The Company had a receivables  financing  arrangement  with a bank which expired
May 31, 1998.  The funds  advanced  ($163,874 at December 28, 1997)  constituted
proceeds under the note which was at an interest rate of prime plus 4.0%;  total
rate  approximately  12.50%.  The Company also paid certain  administrative  and
commitment fees which were less than $1,000/month.

The Company  negotiated a  replacement  working  capital  financing  arrangement
effective August 1998 with an accounts receivable factoring organization.  Under
such an  agreement,  the  factoring  organization  may  purchase  certain of the
Company's  accounts  receivable  subject to full recourse against the Company in
the case of nonpayment by the customers.  The Company generally receives 85%-90%
of the invoice  amount at the time of purchase  and the balance when the invoice
is paid. The Company is charged an interest fee and other processing  charges on
the funded amount, payable at the time each invoice is paid. Funds advanced were
$198,940 as of September 27, 1998.

NOTE 4:       Commitments and Contingencies

LEASE SETTLEMENT

Effective July 1994, the Company settled a legal dispute with a former landlord.
Under the remaining terms of the Settlement Agreement ("Agreement"), the Company
agreed to make  contingent  cash payments of 25% of future earnings (as defined)
and  10-15%  of the net  proceeds  from the sale of  common  stock or  operating
assets.  The Company  also issued an option to purchase up to 125,000  shares of
the  Company's  stock at an exercise  price  (subject to  adjustment)  of $2 per
share.  The option is  exercisable  through  December  31,  2004 and has certain
registration rights upon exercise of the option.

The contingent amounts due are to be paid quarterly.  The period for computation
of such  contingent  payments ends  December  2004.  The $249,000  accrual as of
September 27, 1998 represents the remaining portion which is probable to be paid
over the applicable  consideration period. Of this amount, $80,000 is being paid
at  $10,000  per  month.  The  balance  is  payable  upon  satisfaction  of  the
contingencies as set forth in the Agreement.




                                        9

<PAGE>


                               ESSEX CORPORATION

NOTE 5:       Common Stock Offering; Warrants Outstanding; Preferred Stock;
              Convertible Notes Payable and Debentures

In July 1995, the Company completed a $2.5 million Stock Offering  ("Offering").
Through the  Offering,  the Company  sold 25,000 Units  consisting  of 1,750,000
newly issued shares of common stock and warrants (expiring December 31, 1999 and
exercisable at $75.00 for 25 shares) to obtain an additional 625,000 new shares.

In connection  with the Offering,  the Company  entered into a Placement  Agency
Agreement with a registered broker/dealer. In addition to cash compensation, the
broker/dealer received warrants for 175,000 shares of common stock. The warrants
are exercisable through December 1, 1999 at a price of $2.30 per share,  subject
to  adjustment  under  anti-dilution  provisions of the Warrant  Agreement.  The
warrant  holders  have  certain  registration  rights for these shares of common
stock.

In connection  with the remaining  outstanding  10%  Convertible  Collateralized
Debentures  Due 2000, the Company has reserved  approximately  107,000 shares of
common stock for conversion. In addition, the Company has issued warrants to the
broker/dealer  for 28,571 shares of common stock.  The warrants are  exercisable
through  December 1, 2000 at a price of $3.50 per share,  subject to  adjustment
under  anti-dilution  provisions of the Warrant  Agreement.  The warrant holders
have certain  registration  rights for these shares of common stock. The Company
has also issued  warrants for 78,400 shares to the  purchasers of the Debentures
under  essentially  the same terms and conditions as the warrants  issued to the
broker/dealer.

In January  1997, a class of preferred  stock was approved by the  shareholders.
The  Company's  Articles of  Incorporation  were  amended to authorize 1 million
shares of preferred  stock,  par value $0.01 per share, the series and rights of
which may be designated  from  time-to-time  by the Board of Directors.  In June
1997, the Board designated 2,500 shares of such preferred stock as Series A with
a $100 par value and an 8% annual dividend.  Such shares are redeemable before 1
year from date of issuance at the option of the holder.  These preferred  shares
are  convertible  into shares of Essex common stock at $0.50 per share or market
price,  whichever  is  higher,  and have  certain  other  conversion  protection
features. There were 1,200 shares of preferred stock issued and outstanding. The
preferred  stock plus accrued  dividends  were  converted into 245,796 shares of
common stock in the second quarter of 1998.

The Company  has  reserved  approximately  1,014,000  shares of common  stock in
connection with the convertible debentures and the possible exercise of all such
warrants.

NOTE 6:       Income Taxes

The Company is in a net operating loss (NOL) carryforward  position for book and
tax  purposes.  No tax  benefit  will be  recognized  until  taxable  income  is
realized.

NOTE 7:       Statements of Cash Flows - Supplemental Disclosure

A.            There were no new capital leases entered into in the first 
              thirty-nine weeks of 1998 or 1997.

                                       10

<PAGE>


                                ESSEX CORPORATION


B.            In 1998,  the Company issued 18,000  shares of common stock with a
              market value of $11,880 under its Restricted Stock Bonus Plan.

C.            In  the second  quarter of 1998,  convertible  preferred  stock of
              $120,000 plus accrued dividends was exchanged for common stock.

NOTE 8:       Discontinued Operations

DISCONTINUED OPERATIONS

Effective  June 29,  1997,  the  Board of  Directors  unanimously  approved  the
disposition of the Systems Effectiveness  Division ("SED") and operations of the
Federal  Systems  Division  ("FSD")  except  for  the   telecommunications   and
government-related  optoelectronics  businesses which are comprised of different
customers,  a  separate  location  in  Columbia,  Maryland  and  distinguishable
operations.  The discontinued operations comprised the majority of the Company's
Technical Services and Products business operations.

On August 4, 1997,  the Company  completed the sale of certain of the assets and
operations of FSD for  approximately  $300,000 in cash and assumption of certain
liabilities of approximately  $60,000. There was a contingent payment of $73,000
which was received in early 1998.

Another  portion of the operations of FSD which were performed  primarily in the
Company's  facility in Huntsville,  Alabama were  discontinued  and the facility
closed. The Company settled on the sale of the Huntsville facility in June 1998.

Effective  October 1, 1997, the Company sold the business and net assets of SED.
The  aggregate  sale  price  was  $1,475,000.  The  Company  sold  the  accounts
receivable,  contracts,  fixed assets and certain  other  assets.  The acquiring
company assumed certain liabilities,  such as accounts payable, accrued vacation
and certain operating and capital lease obligations.

The Company received  $525,000 in cash at closing and took a note receivable for
$325,000  which was paid off in June 1998. The balance of $625,000 was placed in
escrow and was received through February 1998 as the respective contracts of SED
were  novated  to the  acquiror.  The  sale  price  is  subject  to  retroactive
adjustment for any change in the net assets and to certain  indemnifications and
warranties  by the Company  which could affect the  ultimate  amount of proceeds
received.

There were no revenues from discontinued  operations in 1998. Summarized results
of operations for 1997 for the discontinued operations are as follows:

<TABLE>
<CAPTION>
                                    NINE MONTHS ENDED SEPTEMBER 28, 1997
                                    ------------------------------------
                                 REVENUES             NET INCOME (LOSS)
                                 --------             -----------------

<S>                       <C>                        <C>                
       SED                $       4,201,000          $           385,000

       FSD                $       1,913,000          $          (412,000)
</TABLE>


                                       11

<PAGE>


                                ESSEX CORPORATION

Net current and noncurrent  assets of discontinued  operations were comprised of
the following:
<TABLE>
<CAPTION>

NET CURRENT ASSETS (LIABILITIES)                          As of
- --------------------------------
                                                    DECEMBER 28, 1997
                                                    -----------------
<S>                                                 <C>              
  Receivables, net                                  $         183,399
  Industrial Revenue Bond - current                           (80,001)
  Other accrued liabilities                                   (72,300)
                                                    -----------------
                                                    $          31,098
                                                    =================

NET NONCURRENT ASSETS
  Property, plant and equipment, net                $       1,050,574
  Industrial Revenue Bond                                     (73,318)
                                                    -----------------
                                                    $         977,256
                                                    =================
</TABLE>

                                       12

<PAGE>


                                ESSEX CORPORATION

ITEM 2.  MANAGEMENT'S DISCUSSION AND ANALYSIS OR PLAN OF OPERATION

MANAGEMENT'S  DISCUSSION  AND ANALYSIS OR PLAN OF OPERATION  AND OTHER  SECTIONS
CONTAIN FORWARD-LOOKING  STATEMENTS THAT ARE BASED ON MANAGEMENT'S EXPECTATIONS,
ESTIMATES, PROJECTIONS AND ASSUMPTIONS. WORDS SUCH AS "EXPECTS",  "ANTICIPATES",
"PLANS",  "BELIEVES",   "ESTIMATES",   VARIATIONS  OF  SUCH  WORDS  AND  SIMILAR
EXPRESSIONS  ARE  INTENDED  TO IDENTIFY  SUCH  FORWARD-LOOKING  STATEMENTS  THAT
INCLUDE,  BUT ARE NOT LIMITED TO,  PROJECTIONS  OF REVENUES,  EARNINGS,  SEGMENT
PERFORMANCE, CASH FLOWS AND CONTRACT AWARDS. SUCH FORWARD-LOOKING STATEMENTS ARE
MADE PURSUANT TO THE SAFE HARBOR PROVISIONS OF THE PRIVATE SECURITIES LITIGATION
REFORM ACT OF 1995.  THESE  STATEMENTS ARE NOT GUARANTEES OF FUTURE  PERFORMANCE
AND INVOLVE  CERTAIN  RISKS AND  UNCERTAINTIES  THAT ARE  DIFFICULT  TO PREDICT.
THEREFORE,  ACTUAL FUTURE RESULTS AND TRENDS MAY DIFFER  MATERIALLY FROM WHAT IS
FORECAST IN FORWARD-LOOKING STATEMENTS DUE TO A VARIETY OF FACTORS. CERTAIN RISK
FACTORS  DISCUSSED IN THIS SECTION AND  ELSEWHERE IN THIS FORM 10-QSB AND IN THE
1997 FORM  10-KSB/A  NO. 1 INCLUDE  BUT ARE NOT  LIMITED  TO:  CONCENTRATION  OF
CURRENT  SALES  WITH  ONE  COMPANY,   LACK  OF  CONTRACT   BACKLOG,   DELAYS  IN
COMMERCIALIZATION  AND SALES OF IMSYN(TM) OPTICAL PROCESSOR UNITS AND ASSOCIATED
INVENTORY  REALIZABILITY  ISSUES, LACK OF WORKING CAPITAL,  IMPORTANCE OF PATENT
PROTECTION  AND  ENFORCEMENT,  AND FUTURE CASH PAYMENT  OBLIGATIONS  TO A FORMER
LANDLORD.

The  Company  was  incorporated  in  Virginia  in 1969 to  provide  professional
engineering and scientific services to support U.S.  Government  defense,  space
and energy programs ("legacy support business").  Since 1988, Company management
has recognized  that its (former) heavy  dependence  upon such program areas had
become vulnerable to declining  government budgets  increasing  competition from
entities far larger than itself.

In 1989, the Company determined that growth,  positional  advantage and relative
ease  of  market   discrimination   were   forwarded   by   acquiring  a  small,
high-technology   venture  in  Columbia,   MD  with   capabilities   in  systems
engineering, signal processing and the design of high-speed, relatively low-cost
optoelectronic  processors. The Company had been heavily committed to performing
systems engineering and signal processing activities for reconnaissance  systems
under contract to the U.S. Government and its prime contractors. This capability
led in 1990 to  initiation of the Company's  continuing  eight-year  association
with  Motorola  as  its  first  Industrial  Partner  on  the  Iridium(R)  global
communications satellite system.

The  Company's  optoelectronics  team has  designed,  developed and sold special
purpose optoelectronic  processors for fifteen years. This experience was gained
in military research and development. In 1989, the Company embarked on a program
to develop proprietary  optoelectronic  processors with significant  performance
advantages over conventional  computers and specialized image processing devices
in such  applications  as  radar  imaging,  magnetic  resonance  imaging  (MRI),
microscopy and ultrawideband signal processing.  A number of patents have issued
to the Company and others are in  prosecution.  The Company is now  applying its
internal  resources to designing  "dual-use"  commercial and military  products,
such as its unique ImSyn(TM) Processor.





                                       13

<PAGE>


                                ESSEX CORPORATION

In  mid-1997,   the  Company's  Board  of  Directors  voted  to  restructure  by
discontinuing  the legacy  support  business  and focusing  upon  optoelectronic
equipment and services and systems and software engineering.  The combination of
optoelectronics  and systems  engineering  is a powerful  discriminator  in both
military and  commercial  markets.  Late in 1997, the sale of the legacy support
business operations was completed. The proceeds are being used in the continuing
operations. Continuing operations reflect the results of optoelectronic products
and services, as well as  telecommunications  engineering services to commercial
and military customers.

CONTINUING OPERATIONS

Revenues were  $1,270,000  and $934,000 for the third quarters of 1998 and 1997,
respectively.  Revenues were $3,313,000 and $2,999,000 for the first thirty-nine
week periods of 1998 and 1997, respectively.  The Company's work for Motorola on
its Iridium cellular  satellite  communication  system accounted for revenues of
$2,399,000  and  $1,358,000  in the  first  three  quarters  of 1998  and  1997,
respectively. This represented 72% and 45% of total revenues for the first three
quarters of 1998 and 1997, respectively.  There was an increase in revenues from
this program between the first three quarters of 1997 and 1998 as more tasks for
Company personnel were received for the initial and follow-on satellite systems.
There was also  $257,000 of work  performed by an outside  subcontractor  in the
1998 third  quarter.  The Company  continues  to perform work on the current and
successor  satellite  systems  and has a backlog  on the  Motorola  programs  of
approximately  $906,000.  As of  September  27,  1998,  the Company had a funded
backlog of  approximately  $255,000 and unfunded backlog of $537,000 on programs
related to optoelectronic devices and services.

The increase in revenues in 1998 on the Motorola contract was offset by the lack
of  ImSyn(TM)   unit  sales  and  lower   revenues  from   contracts  for  other
optoelectronic products and services. There was a sale of one Imsyn(TM) unit for
$250,000  during the first quarter of 1997 for U.S.  Government  end use under a
development and applications contract. The Company does not have any firm orders
for ImSyn(TM) units as of the date of this report.

There was operating  income from  continuing  operations of $67,000 in the third
quarter of 1998  compared to an operating  loss of $196,000 in the third quarter
1997. There were losses of $273,000 and $1,081,000 in the first thirty-nine week
periods of 1998 and 1997, respectively. Cost of goods sold and services provided
for the first  thirty-nine  weeks of 1998 was  53.4%,  higher  than the 49.2% in
1997. The 1998 first thirty-nine week period includes a higher amount of outside
subcontractor  costs on which the Company  receives a smaller profit than on the
work  performed  by  Company  personnel.  Selling,  general  and  administrative
expenses  ("SG&A")  were $1.4  million  in the first  thirty-nine  weeks of 1998
compared to $1.9 million in the first thirty-nine weeks of 1997. The 1997 higher
SG&A expenses  contributed  to the larger loss in 1997.  Overall,  SG&A expenses
remain high relative to the revenue volume as the Company seeks to commercialize
its optoelectronic  products and services. The Company has reduced SG&A expenses
between the 1997 and 1998 periods and has curtailed  expenditures where possible
while  retaining   essential   technical   capabilities  and  personnel  in  the
optoelectronics and telecommunications businesses.




                                       14

<PAGE>


                                ESSEX CORPORATION

DISCONTINUED OPERATIONS

There was income from  discontinued  operations  of $267,000 and $166,000 in the
third quarter and first thirty-nine week periods of 1997, respectively.  Results
from discontinued operations are only applicable to 1997.

Discontinued   operations   are   comprised   of  the  results  of  the  Systems
Effectiveness  Division  and the  operations  of the  Federal  Systems  Division
(except  for  the  telecommunications  and  government-related   optoelectronics
businesses). During 1997, the SED operations had first thirty-nine week sales of
approximately  $4.2 million and produced income of approximately  $385,000.  The
SED operations were sold as of October 1, 1997.

The FSD  discontinued  operation's  revenues  were  $1.9  million  in the  first
thirty-nine  weeks of 1997 and there was a loss from operations of approximately
$412,000.  During  the  first  thirty-nine  weeks of 1997,  FSD was  working  on
completing  a program  to  produce  aviation  maintenance  trainers.  Additional
significant  completion  problems were  encountered in early 1997 which produced
additional  losses. FSD was unable to secure additional new business on a timely
basis  resulting in the  decision to close the  Huntsville,  Alabama  production
facility in September 1997  concurrent  with the  substantial  completion of the
Trainers  Program.  The sale of certain other FSD technical  service  operations
located  elsewhere  was  completed  in  early  August  1997 and the net gain was
reported in the third quarter of 1997.

CORPORATE MATTERS

In  1997,  the  Company's  interest  costs  were  higher  due to  the  financing
associated  with its larger volume of  operations.  Total  interest  expense and
debenture  financing  amortization  costs were $192,000 in the first thirty-nine
week period of 1997 compared to $99,000 in the same period of 1998.

The  Company  recognized  the  majority  of its  remaining  tax  benefit  amount
recoverable  from the  carryback  of net  operating  losses  prior to 1994.  The
Company is in a net operating loss (NOL) carryforward  position. No benefit from
income taxes was recognized in the first thirty-nine weeks of 1998 or 1997.















                                       15

<PAGE>


                                ESSEX CORPORATION

FINANCIAL CONDITION - LIQUIDITY AND CAPITAL RESOURCES

The  Company  evaluates  its  liquidity  position  using  various  factors.  The
following represents some of the more important factors:
<TABLE>
<CAPTION>

                                  SELECTED FINANCIAL DATA ($ Thousands)
                                                              AS OF
                                  --------------------------------------------------------
                                    September 27,       December 28,         September 28,
                                        1998                1997                 1997
                                  ----------------     ---------------      --------------
<S>                               <C>                  <C>                  <C>           
Total Assets                      $          1,910     $         3,191      $        3,967
                                  ================     ===============      ==============

Working Capital (Deficit)         $            491     $           466      $         (470)
                                  ================     ===============      ==============

Current Ratio                               1.44:1              1.36:1              0.82:1

Current and Long-Term
     Capital Leases               $             22     $            65      $           98
Bank Line of Credit/Accounts
     Receivable Financing                      199                 164                 750
Convertible Debentures                         376               1,233               1,400
Convertible Notes Payable                       --                  --                 245
Redeemable Preferred Stock                      --                  --                 120
                                  ----------------     ---------------      --------------
     Total Debt/Financing         $            597     $         1,462      $        2,613
                                  ================     ===============      ==============

Stockholders' Equity (Deficit)    $            415     $           666      $         (183)
                                  ================     ===============      ==============
</TABLE>

The Company  experienced a slight  increase in its working  capital and ratio in
the first  thirty-nine  weeks of 1998. The net loss and the increase in accounts
receivable  were the primary  items of net cash used in  operations in the first
thirty-nine  weeks of 1998.  The 1998 net cash used in operations  was partially
funded by the collection of remaining receivables of discontinued  operations of
$130,000.  The proceeds from the collection of the $411,000 note receivable from
the sale of the discontinued operations was also used to finance operations.

The Company sold its Huntsville,  Alabama facility in the third quarter of 1998.
The  facility  served  as  a  portion  of  the  collateral  on  the  convertible
debentures.  The net  proceeds  of  $875,000  from  the  sale of the  Huntsville
facility were used to partially pay down the debentures.

During mid 1997,  certain insiders and directors invested $120,000 in redeemable
preferred  stock.  The preferred  stock was  converted  into common stock in the
second quarter of 1998.

The Company has incurred significant losses over recent years,  primarily due to
the development and marketing of its optoelectronics  products and services. The
optoelectronics  products and services  business is currently  experiencing  net
cash expenditures (including its respective general and administrative expenses)
over  receipts  in the range of  approximately  $25,000-$50,000  per month.  The
Company  has taken  steps to increase  revenue  volume and reduce  expenditures.
While such actions  produced a modest  improvement  in results in the 1998 third
quarter, if a

                                       16

<PAGE>


                                ESSEX CORPORATION

significant decline in such results occurred, then the Company would not be able
to sustain its  business  without  additional  working  capital or further  cost
reductions.

The  Company  continues  to seek  additional  funds from  financing  sources for
operations and to achieve  desired product  inventory  levels and initial market
penetration.  The  Company  is also  seeking  to  establish  joint  ventures  or
strategic partnerships with major industrial concerns to facilitate these goals.
Significant   further   delays  in  the   commercialization   of  the  Company's
optoelectronic  products,  failure to commercialize  such products or failure to
raise  substantial  additional  working  capital  would have a material  adverse
effect on the Company's future operating results and future financial position.

The Company has  approximately  $400,000 of  inventory in current  assets.  This
inventory is comprised of ImSyn(TM)  optoelectronic  processors  and consists of
finished  goods and  work-in-process.  Sales of such units will be  necessary in
order to maintain working capital liquidity.  There are no firm orders for sales
of such units as of the date of this report.

The receivable financing arrangement for a line of credit up to $500,000 expired
May 31, 1998. The Company  negotiated a replacement  working  capital  financing
arrangement   effective  August  1998  with  an  accounts  receivable  factoring
organization.  Under such an agreement,  the factoring organization may purchase
certain of the Company's  accounts  receivable  subject to full recourse against
the Company in the case of nonpayment by the  customers.  The Company  generally
receives  85%-90% of the invoice  amount at the time of purchase and the balance
when the  invoice is paid.  The  Company is  charged an  interest  fee and other
processing  charges on the funded  amount,  payable at the time each  invoice is
paid. As of September 27, 1998, the Company  received  advances of $199,000 from
the accounts receivable factoring organization.

Under  the  settlement  agreement  reached  with the  former  landlord,  certain
payments are triggered only by other future cash inflows. The remaining $249,000
portion  of the  landlord  settlement  obligation  (which has been  accrued  and
expensed in prior  years),  is not payable  until future  earnings (as defined),
operating asset sales or equity capital  funding occur.  When such future events
transpire,  only a portion of the cash flows or proceeds  generated are payable.
The  sales  of  the  discontinued   operations  of  the  Company  requires  that
approximately  $80,000 of the remaining $249,000 be paid ratably over the next 8
months.

The preceding  paragraphs  discussing the Company's  financial condition contain
forward-looking  statements. The factors affecting the ability of the Company to
meet its funding requirements and manage its cash resources include, among other
things,  the  amount  and  timing of  product  sales,  inventory  turnover,  the
magnitude of fixed costs and the ability to obtain working capital, all of which
involve risks and uncertainties that are difficult to predict.


                                       17

<PAGE>


                                ESSEX CORPORATION
                           PART II - OTHER INFORMATION

Item 6. Exhibits and Report on Form 8-K.

        (a)  Exhibits

             (i)   Exhibit 27 - Financial Data Schedule

                   27.1     Financial Data Schedule

        (b)  Reports on Form 8-K

             The Company  filed a Form 8-K on June 23, 1998 and a Form 8-K/A No.
             1 on July 6,  1998  which  reported  a change in  certified  public
             accountants.

                                    SIGNATURE

In accordance with the requirements of the Securities  Exchange Act of 1934, the
Registrant  caused  this  report to be signed on its behalf by the  undersigned,
thereunto duly authorized.

                                ESSEX CORPORATION
                                  (Registrant)


                          /s/ Joseph R., Kurry, Jr.
Date:   October 21, 1998  -------------------------------------
                                  Joseph R. Kurry, Jr.
                                 Senior Vice President,
                          Treasurer and Chief Financial Officer


(Mr. Kurry is the principal Financial and  Accounting Officer and has been duly 
authorized to sign on behalf of the Registrant.)


                                       18

<TABLE> <S> <C>


<ARTICLE>                       5
                    
                      
<MULTIPLIER>                    1,000
       
<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>               Dec-27-1998
<PERIOD-START>                  Dec-29-1997
<PERIOD-END>                    Sep-27-1998
<CASH>                             232
<SECURITIES>                         0
<RECEIVABLES>                      934
<ALLOWANCES>                       (99)
<INVENTORY>                        401
<CURRENT-ASSETS>                 1,611
<PP&E>                           1,419
<DEPRECIATION>                  (1,317)
<TOTAL-ASSETS>                   1,910
<CURRENT-LIABILITIES>            1,120
<BONDS>                            376
                0
                          0
<COMMON>                           440
<OTHER-SE>                         (26)
<TOTAL-LIABILITY-AND-EQUITY>     1,910
<SALES>                          3,313
<TOTAL-REVENUES>                 3,313
<CGS>                           (1,770)
<TOTAL-COSTS>                   (3,486)
<OTHER-EXPENSES>                     0
<LOSS-PROVISION>                     0
<INTEREST-EXPENSE>                 (99)
<INCOME-PRETAX>                   (273)
<INCOME-TAX>                         0
<INCOME-CONTINUING>               (273)
<DISCONTINUED>                       0
<EXTRAORDINARY>                      0
<CHANGES>                            0
<NET-INCOME>                      (273)
<EPS-PRIMARY>                     (.06)
<EPS-DILUTED>                     (.06)
        


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission